🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Nice to read the news post about the Nature protocols paper of our colleagues on our Institute's website. #CancerResearch #AnimalResearch

🗞️ Published in Clinical Cancer Research, a VHIO-led study that shows the preclinical potential of systemic targeted therapy in pseudomyxoma peritonei. 🤝 This work was supported by the PMPnet #AcceleratorAward.  ➡️ linke.to/CCRENGVHIO

El pseudomixoma peritoneal es un cáncer raro que se origina principalmente en el apéndice y se caracteriza por la acumulación de moco en la cavidad abdominal. Aunque suele tratarse con cirugía, las recaídas son frecuentes, lo que destaca la necesidad de tratamientos más eficaces.

This has been a great MBC Symposium. Excellent speakers and posters leading to thought-provoking discussions and networking to enhance future research collaboration. Patient advocates contributing with relevant and challenging questions. Manchester Cancer Research Centre Division of Cancer Sciences Breast Cancer Now

We are pleased to announce that the registration for the 4th EurOPDX Workshop is now OPEN!

We are pleased to announce that the registration for the #4thEurOPDXWorkshop is now OPEN! forms.office.com/Pages/Response…

At the NKI, we've asked animal facility workers and researchers to share their thoughts on laboratory animal research for fundamental and translational cancer research. Here is one point of view to start your new week. Have a nice week. #CancerResearch

Translational Research bridges the gap between laboratory findings and clinical applications. This type of research explores how research insights can be translated into effective treatments for both animals and humans. #CancerResearch #AnimalResearch

Big congratulations to INFRAFRONTIER. Czech Centre for Phenogenomics is proud to be part of these two initiatives. Institute of Molecular Genetics BIOCEV_SCIENCE

Amongst the hundreds of different types of cancer, cancers of unmet need lack effective treatment and have poor survival rates. Dr Paul Huang and his team are investigating a group of rare cancers called sarcomas. ▶️WATCH youtu.be/Tm1tGsv2Qfg?si… #SarcomaAwarenessMonth

📣 Join us for the Emerging Leaders in Biomedicine Symposium at VHIO!  Co-organized by Josep Carreras Leukaemia Research Institute (IJC), IBEC, IBMB, Centre for Genomic Regulation (CRG), IRB Barcelona, IBUB-UB, UPF Barcelona, and #VHIO.  🗓️ Register now and mark your calendars ➡️ linke.to/EmergingLeader… Pancho Barriga

💡Do you want to know more about the #canSERV_EU project and how to apply for services? Watch back the recording of our canSERV Webinar! ➡️Introduction to canSERV 🎗️ ➡️Browsing the 400+ free tools and services 🔎 ➡️Applying for Calls for Service 💰 youtube.com/watch?v=6-JZDx…

🌍 Fantastic! We’re really excited to see this international collaboration evolve and identify alternative strategies to screen for cervical cancer.

Scientists at Early Cancer Institute, University of Cambridge are using a multi-disciplinary approach to understand the earliest stages of cancer and develop radical new ways to detect and treat it early. #ChangingTheStoryOfCancer Cambridge University Cambridge University Hospitals NHS Cambridge Cancer Research Hospital Science and Innovation at Cancer Research UK zurl.co/J8ox

🚀 Join the Workshop on Mouse Pathobiology with MorphoPHEN & INFRAFRONTIER from 14-16 Oct at Universitat Autònoma de Barcelona. Renowned researchers will share insights on human disease modelling, phenotyping, and more. Free registration via email to [email protected]. ℹ️bit.ly/pathobiology20…

Join us at VHIO for the #4thEurOPDXWorkshop Are you interested in transnational research and preclinical models? Join us at VHIO, Barcelona, from 21 to 23 October - 4 keynote and 4 invited speakers confirmed - 8 EurOPDX Members’ talks - Selected abstracts: slots still available!

🔬#DIAMAV seeks to advance molecular profiling in patients in order to more effectively match personalized treatment  strategies based on the genomic or pathologic profile of each individual patient and the molecular makeup of their disease. ➕linke.to/DIAMAVFEROVHIO

At the NKI, we've asked animal facility workers and researchers to share their thoughts on laboratory animal research for fundamental and translational cancer research, on sticky notes. We'll highlight one here. #CancerResearch #AnimalResearch

✨ Attending ESMO Congress 2024? Don't forget to share your experience with us! When posting about the event, make sure to use #ESMO24 to join the conversation and connect with the global oncology community. Let’s make #ESMO24 an unforgettable experience together! 🌍